<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">14713</article-id><article-id pub-id-type="doi">10.7554/eLife.14713</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-50835"><name><surname>He</surname><given-names>Shuning</given-names></name><aff><institution content-type="dept">Department of Pediatric Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50836"><name><surname>Mansour</surname><given-names>Marc R</given-names></name><aff><institution content-type="dept">Department of Pediatric Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50837"><name><surname>Zimmerman</surname><given-names>Mark W</given-names></name><aff><institution content-type="dept">Department of Pediatric Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50838"><name><surname>Ki</surname><given-names>Dong Hyuk</given-names></name><aff><institution content-type="dept">Department of Pediatric Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50839"><name><surname>Layden</surname><given-names>Hillary M</given-names></name><aff><institution content-type="dept">Department of Pediatric Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50961"><name><surname>Akahane</surname><given-names>Koshi</given-names></name><aff><institution content-type="dept">Department of Pediatric Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55478"><name><surname>Gjini</surname><given-names>Evisa</given-names></name><aff><institution content-type="dept">Center for Immuno-Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32352"><name><surname>de Groh</surname><given-names>Eric D</given-names></name><aff><institution content-type="dept">Department of Cell and Developmental Biology, Penn Cardiovascular Institute, Institute for Regenerative Medicine</institution>, <institution>Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50841"><name><surname>Perez-Atayde</surname><given-names>Antonio R</given-names></name><aff><institution content-type="dept">Department of Pathology, Children's Hospital Boston</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50842"><name><surname>Zhu</surname><given-names>Shizhen</given-names></name><aff><institution content-type="dept">Department of Pediatric Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-30893"><name><surname>Epstein</surname><given-names>Jonathan A</given-names></name><aff><institution content-type="dept">Department of Cell and Developmental Biology, Penn Cardiovascular Institute, and the Institute for Regenerative Medicine</institution>, <institution>Perelman School of Medicine at the University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5081"><name><surname>Look</surname><given-names>A Thomas</given-names></name><aff><institution content-type="dept">Department of Pediatric Oncology, Dana-Farber Cancer Institute</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country><email>thomas_look@dfci.harvard.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5147"><name><surname>Gilbertson</surname><given-names>Richard J</given-names></name><role>Reviewing editor</role><aff><institution>Cambridge Cancer Center, CRUK Cambridge Institute</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>04</month><year>2016</year></pub-date><elocation-id>e14713</elocation-id><supplementary-material><ext-link xlink:href="elife-14713-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>26</day><month>01</month><year>2016</year></date><date date-type="accepted"><day>26</day><month>04</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, He et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>He et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Earlier reports showed that hyperplasia of sympathoadrenal cell precursors during embryogenesis in <italic>Nf1</italic>-deficient mice is independent of Nf1's role in down-modulating RAS-MAPK signaling. We demonstrate in zebrafish that  <italic>nf1</italic> loss leads to aberrant activation of RAS signaling in <italic>MYCN</italic>-induced neuroblastomas that arise in these precursors, and that the GTPase-activating protein (GAP)-related domain (GRD) is sufficient to suppress the acceleration of neuroblastoma in <italic>nf1</italic>-deficient fish, but not the hypertrophy of sympathoadrenal cells in <italic>nf1</italic> mutant embryos. Thus, even though neuroblastoma is a classical 'developmental tumor', NF1 relies on a very different mechanism to suppress malignant transformation than it does to modulate normal neural crest cell growth. We also show marked synergy in tumor cell killing between MEK inhibitors (trametinib) and retinoids (isotretinoin) in primary <italic>nf1a-/-</italic> zebrafish neuroblastomas. Thus, our model system has considerable translational potential for investigating new strategies to improve the treatment of very high-risk neuroblastomas with aberrant RAS-MAPK activation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All zebrafish studies and maintenance of the animals were performed in accordance with Dana-Farber Cancer Institute IACUC-approved protocol (#02-107).</p></fn></fn-group></back></article>